Metronomic chemotherapy may be active in heavily pre-treated patients with metastatic adreno-cortical carcinoma. (Q46096086)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22522572%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Metronomic chemotherapy may be active in heavily pre-treated patients with metastatic adreno-cortical carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22522572%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22522572%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Massimo Terzolo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22522572%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

A Ferrero

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22522572%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

P Sperone

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22522572%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

A Ardito

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22522572%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

G Rossi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22522572%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

S Del Buono

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22522572%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

A M Priola

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22522572%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

S Bracarda

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22522572%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

A Berruti

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22522572%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

5 April 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22522572%20AND%20SRC:MED&resulttype=core&format=json

Journal of Endocrinological Investigation

29 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22522572%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22522572%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22522572%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

148-152

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22522572%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.3275/8334

29 January 2020

exact match

0 references

cites work

Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial

1 reference

12 December 2020

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

12 December 2020

Low dose metronomic oral cyclophosphamide for hormone resistant prostate cancer: a phase II study.

1 reference

12 December 2020

Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group

1 reference

12 December 2020

Clinical review: Adrenocortical carcinoma: clinical update

1 reference

12 December 2020

Plasma concentrations of o,p'DDD, o,p'DDA, and o,p'DDE as predictors of tumor response to mitotane in adrenocortical carcinoma: results of a retrospective ENS@T multicenter study

1 reference

12 December 2020

Oral metronomic cyclophosphamide in elderly with metastatic melanoma

1 reference

12 December 2020

Emerging drugs for adrenocortical carcinoma

1 reference

12 December 2020

Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study

1 reference

12 December 2020

The Italian Registry for Adrenal Cortical Carcinoma: analysis of a multiinstitutional series of 129 patients. The ACC Italian Registry Study Group

1 reference

12 December 2020

Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinoma

1 reference

12 December 2020

Metronomic chemotherapy: principles and lessons learned from applications in the treatment of metastatic prostate cancer

1 reference

12 December 2020

The anti-angiogenic basis of metronomic chemotherapy

1 reference

12 December 2020

Understanding tumor endothelial cell abnormalities to develop ideal anti-angiogenic therapies

1 reference

12 December 2020

Identifiers

DOI

10.3275/8334

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22522572%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

29 January 2020

0 references

1 reference